ATE425758T1 - Modifizierte polysaccharide mit veranderter biologischer erkennung - Google Patents

Modifizierte polysaccharide mit veranderter biologischer erkennung

Info

Publication number
ATE425758T1
ATE425758T1 AT98962025T AT98962025T ATE425758T1 AT E425758 T1 ATE425758 T1 AT E425758T1 AT 98962025 T AT98962025 T AT 98962025T AT 98962025 T AT98962025 T AT 98962025T AT E425758 T1 ATE425758 T1 AT E425758T1
Authority
AT
Austria
Prior art keywords
altered biological
biological detection
modified polysaccharides
polysaccharides
altered
Prior art date
Application number
AT98962025T
Other languages
English (en)
Inventor
Bo Hedlund
Thomas Weber
Paul Dragsten
Gregory Hanson
Philip Hallaway
Original Assignee
Biomed Frontiers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomed Frontiers Inc filed Critical Biomed Frontiers Inc
Application granted granted Critical
Publication of ATE425758T1 publication Critical patent/ATE425758T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98962025T 1997-12-09 1998-12-09 Modifizierte polysaccharide mit veranderter biologischer erkennung ATE425758T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6907997P 1997-12-09 1997-12-09
US6909597P 1997-12-11 1997-12-11

Publications (1)

Publication Number Publication Date
ATE425758T1 true ATE425758T1 (de) 2009-04-15

Family

ID=26749664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962025T ATE425758T1 (de) 1997-12-09 1998-12-09 Modifizierte polysaccharide mit veranderter biologischer erkennung

Country Status (12)

Country Link
US (1) US6479468B1 (de)
EP (1) EP1037642B9 (de)
JP (1) JP4435412B2 (de)
AT (1) ATE425758T1 (de)
AU (1) AU761784B2 (de)
BR (1) BR9813465A (de)
CA (1) CA2314716C (de)
DE (1) DE69840673D1 (de)
DK (1) DK1037642T3 (de)
ES (1) ES2325005T3 (de)
TR (1) TR200001682T2 (de)
WO (1) WO1999029328A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
CA2460042C (en) * 2000-09-26 2012-05-08 Sidney Kimmel Cancer Center Inhibition of antigen presentation with poorly catabolized polymers
EP1707632A1 (de) * 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
BR112012009014B8 (pt) 2009-09-30 2022-10-04 Novartis Ag Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica
EP3821880A1 (de) 2015-10-26 2021-05-19 President and Fellows of Harvard College Oxidierte polysaccharide und verfahren zur verwendung davon
WO2018229117A1 (en) * 2017-06-13 2018-12-20 Merz Pharma Gmbh & Co. Kgaa Mixing nozzle, application device, kit and method using the mixing nozzle or application device
JP7166300B2 (ja) * 2017-07-06 2022-11-07 バイエル、アクチエンゲゼルシャフト 雑草防除装置

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB977694A (en) * 1959-12-23 1964-12-09 Chugai Pharmaceutical Co Ltd Starch derivatives
DE1186076B (de) 1960-10-11 1965-01-28 Ciba Geigy Verfahren zur Gewinnung komplexmetallfreier Ferrioxamine
JPS5634701A (en) * 1979-08-29 1981-04-07 Meito Sangyo Kk Beta-1,3-glucan, its preparation and use
US4419365A (en) 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4863964A (en) 1985-07-02 1989-09-05 Biomedical Frontiers, Inc. Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
US5217998A (en) 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
US4863961A (en) * 1985-11-25 1989-09-05 G. D. Searle & Co. Tetraenyl prostaglandins
US4987253A (en) 1988-09-19 1991-01-22 University Of Florida Method for the synthesis of desferrioxamine B and analogs thereof
US5268165A (en) 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5493053A (en) 1994-12-21 1996-02-20 University Of Florida Research Foundation, Inc. Method for preparing desferrioxamine B and homologs thereof
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US5847110A (en) 1997-08-15 1998-12-08 Biomedical Frontiers, Inc. Method of reducing a schiff base

Also Published As

Publication number Publication date
DK1037642T3 (da) 2009-07-06
ES2325005T3 (es) 2009-08-21
JP2001525369A (ja) 2001-12-11
DE69840673D1 (de) 2009-04-30
TR200001682T2 (tr) 2001-02-21
JP4435412B2 (ja) 2010-03-17
EP1037642B1 (de) 2009-03-18
EP1037642A1 (de) 2000-09-27
EP1037642B9 (de) 2010-10-13
AU761784B2 (en) 2003-06-12
BR9813465A (pt) 2002-01-22
US6479468B1 (en) 2002-11-12
WO1999029328A1 (en) 1999-06-17
CA2314716A1 (en) 1999-06-17
CA2314716C (en) 2009-02-03
AU1719799A (en) 1999-06-28

Similar Documents

Publication Publication Date Title
ES2110386T3 (es) Conjugados de interferon.
DE69830326D1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
HN1996000017A (es) Isotiazolonas
PT871619E (pt) Derivados de fenil-tiazol com propriedades anti-virus do herpesc
TR199600351A2 (tr) Iyilestirilmis mekanik özelliklere sahip polietilen boru.
ATE196479T1 (de) Mit antioxidantien gepfropfte polysaccharide und deren verwendungen
DE60010098D1 (de) 28-epirapaloge
ID23374A (id) Halogenopirimidin
ATE259830T1 (de) Polymerkomplexe von glukuronoglukanen
DE50012863D1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
EP1575534A4 (de) D4,5 glycuronidase und ihre verwendungen
BR9711117A (pt) Oligossacarídios modificados.
NO974564D0 (no) Karbohydratmodifiserte cytostatika
DE69902010D1 (de) Kardierbare doppelglasfasermischung
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
ATE425758T1 (de) Modifizierte polysaccharide mit veranderter biologischer erkennung
FR2753978B1 (fr) Composition thermodurcissable, ses utilisations et preforme souple depliable comprenant cette composition
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
FI965064L (fi) Veteenliukeneva suurimolekyylinen yhdiste, joka sisältää silikonia ja sen tuotanto ja käyttö
ATE298373T1 (de) Immunstimulierende phellinus ssp. polysaccharid und verwendung
EA200400393A1 (ru) Антитела против каспазы-8, их получение и применение
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
EP1127062A4 (de) Lymphomassozierte moleküle und ihre anwendungen
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties